Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury

Transplantation

Volumn 76, Issue 11, 2003, Pages 1594-1599

  Fuller, T Florian ^a   Freise, Chris E ^b   Serkova, Natalie ^c   Niemann, Claus U ^d   Olson, Jean L ^b   Feng, Sandy ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; UNIVERSITY OF WISCONSIN SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CREATININE BLOOD LEVEL; CRYOPRESERVATION; DISEASE MODEL; DRUG EFFECT; GRAFT SURVIVAL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; ISOGRAFT; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURVIVAL TIME; TISSUE REGENERATION; TISSUE REPAIR;

ADENOSINE; ALLOPURINOL; ANIMALS; CREATININE; GLUTATHIONE; IMMUNOSUPPRESSIVE AGENTS; INSULIN; KIDNEY; KIDNEY TRANSPLANTATION; ORGAN PRESERVATION SOLUTIONS; RAFFINOSE; RATS; REPERFUSION INJURY; SIROLIMUS; TIME FACTORS; TRANSPLANTATION, ISOGENEIC; TREATMENT OUTCOME;

EID: 0346848743     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000095897.38634.30     Document Type: Article

References (22)

1. Halloran PF, Hunsicker LG. Delayed graft function: state of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001; 1: 115.
2. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995; 59: 962.
3. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
4. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: 1697.
5. Kyllonen LE, Salmela KT, Eklund BH, et al. Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transpl Int 2000; 13: 122.
6. Canafax DM, Torres A, Fryd DS, et al. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation 1986; 41: 177.
7. Novick AC, Hwei HH, Steinmuller D, et al. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study. Transplantation 1986; 42: 154.
8. Sehgal SN. Rapamune (sirolimus, rapamycin): an overview and mechanism of action. Ther Drug Monit 1995; 17: 660.
9. Smith KD, Wrenshall LE, Nicosia RF, et al. Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 2003; 14: 1037.
10. Lieberthal W, Fuhro R, Andry CC, et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 2001; 281: F693.
11. Andoh TF, Burdmann EA, Fransechini N, et al. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 1996; 50: 1110.
12. McTaggart RA, Gottlieb D, Brooks J, et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003; 3: 416.
13. Fisher B, Lee S. Microvascular surgical technique in research with special reference to renal transplantation in the rat. Surgery 1965; 58: 904.
14. Christians U, Jacobsen W, Serkova N, et al. Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants. J Clin Chromatogr B Biomed Sci Appl 2000; 748: 41.
15. DiJoseph JF, Fluhler E, Armstrong J, et al. Therapeutic blood levels of sirolimus (rapamycin) in the allografted rat. Transplantation 1996; 62: 1109.
16. DiJoseph JF, Sharma RN, Chang JY. The effect of rapamycin on kidney function in the Sprague-Dawley rat. Transplantation 1992; 53: 507.
17. Fryer J, Yatscoff RW, Pascoe EA, et al. The relationship of blood concentrations of rapamycin and cyclosporine to suppression of allograft rejection in a rabbit heterotopic heart transplant model. Transplantation 1993; 55: 340.
18. Stepkowski SM, Napoli KL, Wang ME, et al. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats. Transplantation 1996; 62: 986.
19. Gonzalez N, Alvarez V, Pons H, et al. Mycophenolate mofetil aggravates postischemic acute renal failure in rats. Transplant Proc 2002; 34: 43.
20. Sun DF, Fujigaki Y, Fujimoto T, et al. Mycophenolate mofetil inhibits regenerative repair in uranyl acetate- induced acute renal failure by reduced interstitial cellular response. Am J Pathol 2002; 161: 217.
21. Jones EA, Shoskes DA. The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair. J Urol 2000; 163: 999.
22. Andoh TF, Choi S-O, Wakba IM, et al. Beneficial effect of mycophenolate mofetil (MMF) in sirolimus (SRL) induced delayed renal function in post-ischemic rat kidney. Am J Transplant 2002; A 96, S3: 161.